Adeno-associated viral (AAV) vectors play a central role in the delivery of gene therapies and as a vehicle for gene editing approaches. The Center for Breakthrough Medicines offers a full range of AAV production scales and platforms to serve the research, preclinical, clinical and commercial manufacturing clients including:
- Transient transfection in both adherent and suspension cells
- Baculovirus and other viral co-infection methods
- Producer cell lines
- Single-use technologies for streamlined clinical development processes
- Testing and product characterization using next-generation analytical methods
